Pedro Norton

Pedro Norton

Auto-generated profile, based on publicly available information

Pedro Norton

Serviço de Saúde Ocupacional. Unidade Local de Saúde de São João, EPE. Porto. Portugal

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MPM Francisca Portilha-Cunha
M Francisca Portilha-Cunha
SRSara Ramos
Sara Ramos
Adriano dos Santos SilvaAdriano dos Santos Silva
Adriano dos Santos Silva
PNPedro Norton
Pedro Norton
AAA. Alves
A. Alves
Mónica SantosMónica Santos
Mónica Santos
Cytostatics are drugs used in cancer treatment, which pose serious risks to healthcare workers. Dermal absorption via surface contamination is the key exposure route; thus, rapid, reliable, and validated analytical methods for multicomponent detection are crucial to identify the exposure risk. A surface-wipe-sampling technique compatible with hospitals’ safety requirements (gauze, 1 mL isopropanol) and a fast and simple extraction method (1 mL acetonitrile, 20 min ultrasonic bath, evaporation, reconstitution in 200 µL acetonitrile), coupled with liquid chromatography–tandem mass spectrometry analysis, were developed. It allowed identification and quantification of 13 cytostatics on surfaces: cyclophosphamide, doxorubicin, etoposide, ifosfamide, paclitaxel, bicalutamide, capecitabine, cyproterone, flutamide, imatinib, megestrol, mycophenolate mofetil, prednisone. Good linearity, sensitivity, and precision were achieved (R2 > 0.997, IDLs < 4.0 pg/cm2, average CV 16%, respectively). Accuracy for four model surfaces (melamine-coated wood, phenolic compact, steel 304, steel 316) was acceptable (80 ± 12%), except for capecitabine and doxorubicin. Global uncertainty is below 35% for concentrations above 100 pg/cm2 (except for capecitabine and doxorubicin)—a guidance value for relevant contamination. Method application in a Portuguese university hospital (28 samples) identified the presence of seven cytostatics, at concentrations below 100 pg/cm2, except for three samples. The widespread presence of cyclophosphamide evinces the necessity to review implemented procedures.

28 March 2022 in Foods
Verified
Journal Article
Open access
PDF file
TSTânia Silva-Santos
Tânia Silva-Santos
Pedro MoreiraPedro Moreira
Pedro Moreira
OPOlívia Pinho
Olívia Pinho
PPPatrícia Padrão
Patrícia Padrão
PNPedro Norton
Pedro Norton
Carla GonçalvesCarla Gonçalves
Carla Gonçalves
(1) Background: Excessive salt intake is associated with an increased risk of hypertension and cardiovascular disease, so reducing it is critical. The main objective of this study was to verify whether one intervention to reduce added salt during cooking changed knowledge, attitudes and behavior (KAB) towards salt, and to analyze changes in the main sources of salt. (2) Methods: The intervention study was an 8-week randomized controlled trial with 97 workers from a public university. KAB in relation to salt were obtained through the WHO STEPwise questionnaire, and the main sources of salt were obtained by 24-h food recall and 24 h urinary sodium excretion over two days. (3) Results: After the intervention, participants in the intervention group reported a decrease in the addition of salt when cooking (p = 0.037), an increase in the percentage of subjects who avoided the consumption of processed foods (from 54.2% to 83.3%, p = 0.001), who looked for salt on food labels (from 18.8% to 39.6%, p = 0.013), and who bought low-salt food alternatives (from 43.8% to 60.4%, p = 0.039). However, there were no significant differences between the intervention group and the control group at baseline and post-intervention assessments. In the intervention group, after the intervention, the added salt decreased by 5%; food sources of salt such as the snacks and pizza group decreased by 7%, and the meat, fish and eggs group increased by 4%, but without statistical significance. (4) Conclusions: With innovative equipment for dosing salt when cooking, it is possible to change some dimensions of consumer behavior in relation to salt.

21 December 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
TSTânia Silva-Santos
Tânia Silva-Santos
Pedro MoreiraPedro Moreira
Pedro Moreira
OPOlívia Pinho
Olívia Pinho
PPPatrícia Padrão
Patrícia Padrão
SASandra Abreu
Sandra Abreu
Carla GonçalvesCarla Gonçalves
Carla Gonçalves
(1) Background: Excessive salt consumption is associated with an increased risk of hypertension and cardiovascular disease, and it is essential to reduce it to the level recommended by the World Health Organization (<5 g/day). The main objective of this study is to verify the impact of an intervention, which used the Salt Control H equipment to reducing salt consumption; (2) Methods: The study was an 8-week randomized control trial with 114 workers from a public university. The intervention group (n = 57) used the equipment to monitor and control the use of salt during cooking (Salt Control H) at home for 8 weeks. The primary outcome was 24 h urinary sodium excretion as a proxy of salt intake. Secondary outcomes included changes in 24 h urinary potassium excretion, sodium to potassium ratio (Na:K), and blood pressure. (3) Results: There was a decrease in sodium intake after the intervention but with no statistical significance. When analyzing the results by sex and hypertension status, there was a reduction in sodium (−1009 (−1876 to −142), p = 0.025) and in Na:K ratio (−0.9 (−1.5 to −0.3), p = 0.007) in hypertensive men in the intervention group. (4) Conclusions: Interventions with dosage equipment can be valid approaches in individual salt reduction strategies, especially in hypertensive men.

21 January 2025 in Journal of Occupational and Environmental Hygiene
Verified
Journal Article
Closed access
MPM Francisca Portilha-Cunha
M Francisca Portilha-Cunha
PNPedro Norton
Pedro Norton
AAA. Alves
A. Alves
Ana RibeiroAna Ribeiro
Ana Ribeiro
Adriano dos Santos SilvaAdriano dos Santos Silva
Adriano dos Santos Silva
Mónica SantosMónica Santos
Mónica Santos
Effective decontamination of hospital surfaces is crucial to protect workers from antineoplastic drugs (ADs) since dermal absorption is the main exposure route to these hazardous medicinal products. Sampling after daily cleaning in oncologic settings from a tertiary hospital was initially performed and exhibited low contamination levels; however, cyclophosphamide was still found (up to 957 pg/cm2) above the guidance value (100 pg/cm2) in four locations, evidencing the need to properly assess and update the cleaning protocols. Then, cleaning efficiencies of six solutions and different protocols were evaluated (including, for the first time, four commercial cleaning solutions/disinfectants not designed specifically for AD removal) after deliberate contamination of three model surfaces with 13 pharmaceuticals: bicalutamide, capecitabine, cyclophosphamide, cyproterone, doxorubicin, etoposide, flutamide, ifosfamide, imatinib, megestrol, mycophenolate mofetil, paclitaxel, and prednisone. Wipe sampling and liquid chromatography-tandem mass spectrometry were employed to determine surface contamination after cleaning. Results revealed that: (i) none of the solutions or procedures totally removed all target pharmaceuticals from surfaces; (ii) the removal efficiency increased with cleaning steps (average removals above 90% were attained for Vyclean and Clinell Universal Spray using two cleaning steps); and (iii) the cleaning efficiency was likely favored by the application of the solution/disinfectant directly on the surfaces. Therefore, considering the dissimilar chemical structures and properties of the numerous ADs in use, the cleaning agent and protocol should be adjusted to the reality of each healthcare unit. Still, the scientific community is encouraged to develop a cleaning solution/protocol to simultaneously eliminate/remove as many ADs as possible.

1 January 2021 in Porto Biomedical Journal
Verified
Journal Article
Open access
PNPedro Norton
Pedro Norton
JGJoao Guimaraes
Joao Guimaraes
PPPaulo Pinho
Paulo Pinho
MRManuela Ribeiro
Manuela Ribeiro
Natália Cruz-MartinsNatália Cruz-Martins
Natália Cruz-Martins
CMCarlos Pedro Mendes
Carlos Pedro Mendes
Objectives: The aim of the study was to evaluate the presence of bacterial contamination on biometric identification devices in a public hospital; identify the species of bacteria implicated in the contamination and assess bacterial recovery after the use of 2 types of disinfectants: alcohol 70% and isopropyl alcohol chlorhexidine. Design: Before and after trial. Setting: Public hospital, tertiary referral center. Participants: All existing biometric identification devices in the hospital (n = 20). Methods: Collection of 2 microbiological samples from the fingerprint reading surface of biometric devices immediately before and after applying the solution with alcohol 70% and in separate time periods with isopropyl alcohol chlorhexidine. Results: It have been identified 21 different bacterial species in a total of 78 samples, mostly Staphylococcus epidermidis (32 samples) and S aureus (7 samples). S epidermidis was eliminated in 61.5% of the samples after disinfecting with alcohol 70% and in 92.3% of the samples disinfected with isopropyl alcohol chlorhexidine. S aureus was eliminated in 33.3% and 100% of the samples, respectively. We found no bacterial growth in 10% of the devices after disinfection with 70% alcohol and in 78.9% of devices after disinfection with isopropyl alcohol chlorhexidine. We also found that there was a decrease in the frequency of species isolated after using both disinfection solutions, although isopropyl alcohol chlorhexidine appeared to be more effective. Conclusions: The biometric identification devices used in this hospital seem to be safe regardless of the products used for its cleaning. The majority of the bacteria found are commensal skin microorganisms. We did not find pathogenic bacteria for immunocompetent individuals, in particular methicillin-resistant S aureus.

1 April 2025 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
VTVanessa Teófilo
Vanessa Teófilo
JAJoana Amaro
Joana Amaro
PMPedro Matos
Pedro Matos
PPPaulo Pinho
Paulo Pinho
SMSalomé Moreira
Salomé Moreira
PNPedro Norton
Pedro Norton
Introdução: A hesitação vacinal é reconhecida pela Organização Mundial da Saúde como uma das principais ameaças à saúde global, tendo adquirido contornos singulares no contexto da pandemia da COVID-19. Os profissionais de saúde são reconhecidos como uma das fontes de informação mais confiáveis relativamente à vacinação. A sua posição perante a imunização constitui um fator determinante da sua intenção de a recomendar a terceiros, com potencial repercussão na taxa de adesão à vacina na população geral. O objetivo deste estudo foi caracterizar do ponto de vista sociodemográfico os profissionais de saúde de um hospital terciário português que recusaram a vacinação contra a COVID-19 e analisar os motivos da hesitação/recusa e intenção de vacinação no futuro.Métodos: Estudo observacional transversal conduzido em 2021, cuja população-alvo compreende os profissionais de saúde propostos a completar o esquema vacinal primário contra a COVID-19. Aos que recusaram a vacinação, foi solicitado o preenchimento do “Questionário de Não-Vacinação COVID-19”, que incluía uma questão de escolha múltipla e um campo de resposta livre sobre os motivos da hesitação/recusa e a pretensão de vacinação no futuro. Foram analisadas as variáveis ‘sexo’, ‘idade’ e ‘categoria profissional’. Resultados: Entre os 6648 profissionais de saúde da amostra, 2,3% (n = 153) recusaram realizar o esquema vacinal completo. A média de idades foi de 46 anos (DP = 11), sendo a proporção, em cada grupo etário de 1,2% com ≤ 35 anos; 2,5% com 36 - 45 anos; 3,1% com > 45 anos. A taxa de recusa vacinal, entre o total de profissionais de cada sexo, foi de 2,3% no sexo feminino e 2,4% no masculino. Uma maior proporção de recusa ocorreu nos assistentes operacionais (n = 53, 4,0%) e assistentes técnicos (n = 13, 3,0%). Observaram-se 16 motivos de hesitação/recusa vacinal, sendo os mais relatados: receio de reações adversas (n = 31), investigação insuficiente das vacinas (n = 22), desconfiança na eficácia das vacinas (n = 25). Apenas 28,1% (n = 43) demonstraram intenção de vacinação no futuro. Conclusão: Verificou-se uma elevada taxa de aceitação do esquema vacinal primário contra a COVID-19. A probabilidade de recusa vacinal foi semelhante entre ambos os sexos, mas superior em indivíduos com mais de 45 anos e nos assistentes operacionais. Destacaram-se os motivos de recusa vacinal que pressupunham preocupações relativas à segurança da vacina. Estudos adicionais são necessários para melhor compreensão das dinâmicas subjacentes à hesitação/recusa vacinal.